Procalcitonin as a diagnostic marker of ventilator‑associated pneumonia in cardiac surgery patients

Jiao,Jia; Wang,Min; Zhang,Jianfeng; Shen,Kangjun; Liao,Xiaobo; Zhou,Xinmin

doi:10.3892/etm.2015.2175

Procalcitonin as a diagnostic marker of ventilator‑associated pneumonia in cardiac surgery patients

Authors:
- Jia Jiao
- Min Wang
- Jianfeng Zhang
- Kangjun Shen
- Xiaobo Liao
- Xinmin Zhou
View Affiliations

Affiliations: Department of Cardiothoracic Surgery, The Second Xiangya Hospital, Central South University, Changsha, Hunan 410011, P.R. China
Published online on: January 9, 2015 https://doi.org/10.3892/etm.2015.2175
Pages: 1051-1057

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The aim of the present study was to assess whether procalcitonin (PCT) can be used as a diagnostic marker for ventilator‑associated pneumonia (VAP) in cardiac surgery patients. Between January 2012 and June 2013, a total of 92 patients were recruited and divided into non‑VAP (59 patients) and VAP (33 patients) groups. The preoperative and postoperative characteristics of the patients were recorded. Serum levels of PCT, interleukin (IL)‑6 and C‑reactive protein (CRP) were measured using an electrochemiluminescence immunoassay. Subsequently, receiver operating characteristic curves of the PCT, IL‑6 and CRP levels were constructed. In addition, associations between the sequential organ failure assessment (SOFA) scores and the serum levels of PCT, IL‑6 and CRP in the VAP patients were analyzed. No statistically significant difference was observed between the non‑VAP and VAP patients in the occurrence of postoperative complications. However, the SOFA scores (days 1 and 7), the duration of stay in the intensive care unit and the mechanical ventilation time were all significantly higher in the VAP group when compared with the non‑VAP group (P<0.05). The optimum PCT cut‑off value for VAP diagnosis on day 1 was 5.0 ng/ml, with a sensitivity of 91% and a specificity of 71%. The serum PCT levels on days 1 and 7 were found to correlate positively with the SOFA scores (r=0.54 and r=0.66 for days 1 and 7, respectively). Therefore, the results suggested that serum PCT may be used as diagnostic marker for VAP in patients following cardiac surgery.

View Figures

View References

1	Hortal J, Giannella M, Pérez MJ, et al: Incidence and risk factors for ventilator-associated pneumonia after major heart surgery. Intensive Care Med. 35:1518–1525. 2009. View Article : Google Scholar : PubMed/NCBI
2	Vijarnsorn C, Winijkul G, Laohaprasitiporn D, et al: Postoperative fever and major infections after pediatric cardiac surgery. J Med Assoc Thai. 95:761–770. 2012.PubMed/NCBI
3	Melsen WG, Rovers MM, Groenwold RH, et al: Attributable mortality of ventilator-associated pneumonia: a meta-analysis of individual patient data from randomised prevention studies. Lancet Infect Dis. 13:665–671. 2013. View Article : Google Scholar : PubMed/NCBI
4	Hortal J, Muñoz P, Cuerpo G, Litvan H, Rosseel PM and Bouza E; European Study Group on Nosocomial Infections; European Workgroup of Cardiothoracic Intensivists. Ventilator-associated pneumonia in patients undergoing major heart surgery: an incidence study in Europe. Crit Care. 13:R802009. View Article : Google Scholar : PubMed/NCBI
5	Roeleveld PP, Guijt D, Kuijper EJ, Hazekamp MG, de Wilde RB and de Jonge E: Ventilator-associated pneumonia in children after cardiac surgery in The Netherlands. Intensive Care Med. 37:1656–1663. 2011. View Article : Google Scholar : PubMed/NCBI
6	Tamayo E, Álvarez FJ, Martínez-Rafael B, et al: Valladolid Sepsis Study Group: Ventilator-associated pneumonia is an important risk factor for mortality after major cardiac surgery. J Crit Care. 27:18–25. 2012. View Article : Google Scholar
7	Becker KL, Snider R and Nylen ES: Procalcitonin assay in systemic inflammation, infection, and sepsis: clinical utility and limitations. Crit Care Med. 36:941–952. 2008. View Article : Google Scholar : PubMed/NCBI
8	Assicot M, Gendrel D, Carsin H, Raymond J, Guilbaud J and Bohuon C: High serum procalcitonin concentrations in patients with sepsis and infection. Lancet. 341:515–518. 1993. View Article : Google Scholar : PubMed/NCBI
9	Riedel S: Procalcitonin and the role of biomarkers in the diagnosis and management of sepsis. Diagn Microbiol Infect Dis. 73:221–227. 2012. View Article : Google Scholar : PubMed/NCBI
10	Rea-Neto A, Youssef NC, Tuche F, et al: Diagnosis of ventilator-associated pneumonia: a systematic review of the literature. Crit Care. 12:R562008. View Article : Google Scholar : PubMed/NCBI
11	Sponholz C, Sakr Y, Reinhart K and Brunkhorst F: Diagnostic value and prognostic implications of serum procalcitonin after cardiac surgery: a systematic review of the literature. Crit Care. 10:R1452006. View Article : Google Scholar : PubMed/NCBI
12	Adib-Conquy M, Monchi M, Goulenok C, et al: Increased plasma levels of soluble triggering receptor expressed on myeloid cells 1 and procalcitonin after cardiac surgery and cardiac arrest without infection. Shock. 28:406–410. 2007. View Article : Google Scholar : PubMed/NCBI
13	Sinning JM, Scheer AC, Adenauer V, et al: Systemic inflammatory response syndrome predicts increased mortality in patients after transcatheter aortic valve implantation. Eur Heart J. 33:1459–1468. 2012. View Article : Google Scholar : PubMed/NCBI
14	American Thoracic Society; Infectious Diseases Society of America. Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med. 171:388–416. 2005. View Article : Google Scholar : PubMed/NCBI
15	Vincent JL, Moreno R, Takala J, et al: The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med. 22:707–710. 1996. View Article : Google Scholar : PubMed/NCBI
16	Duflo F, Debon R, Monneret G, Bienvenu J, Chassard D and Allaouchiche B: Alveolar and serum procalcitonin: diagnostic and prognostic value in ventilator-associated pneumonia. Anesthesiology. 96:74–79. 2002. View Article : Google Scholar
17	Oppert M, Reinicke A, Müller C, Barckow D, Freix U and Eckardt KU: Elevations in procalcitonin but not C-reactive protein are associated with pneumonia after cardiopulmonary resuscitation. Resuscitation. 53:167–170. 2002. View Article : Google Scholar : PubMed/NCBI
18	Luyt CE, Combes A, Reynaud C, et al: Usefulness of procalcitonin for the diagnosis of ventilator-associated pneumonia. Intensive Care Med. 34:1434–1440. 2008. View Article : Google Scholar : PubMed/NCBI
19	Hensel M, Volk T, Döcke WD, et al: Hyperprocalcitonemia in patients with noninfectious SIRS and pulmonary dysfunction associated with cardiopulmonary bypass. Anesthesiology. 89:93–104. 1998. View Article : Google Scholar : PubMed/NCBI
20	Amin DN, Pruitt JC and Schuetz P: Influence of major cardiopulmonary surgery on serum levels of procalcitonin and other inflammatory markers. Anaesth Intensive Care. 40:760–766. 2012.PubMed/NCBI
21	Beghetti M, Rimensberger PC, Kalangos A, Habre W and Gervaix A: Kinetics of procalcitonin, interleukin 6 and C-reactive protein after cardiopulmonary-bypass in children. Cardiol Young. 13:161–167. 2003. View Article : Google Scholar : PubMed/NCBI
22	Meisner M, Rauschmayer C, Schmidt J, et al: Early increase of procalcitonin after cardiovascular surgery in patients with postoperative complications. Intensive Care Med. 28:1094–1102. 2002. View Article : Google Scholar : PubMed/NCBI
23	Jebali MA, Hausfater P, Abbes Z, Aouni Z, Riou B and Ferjani M: Assessment of the accuracy of procalcitonin to diagnose postoperative infection after cardiac surgery. Anesthesiology. 107:232–238. 2007. View Article : Google Scholar : PubMed/NCBI
24	Prat C, Ricart P, Ruyra X, et al: Serum concentrations of procalcitonin after cardiac surgery. J Card Surg. 23:627–632. 2008. View Article : Google Scholar : PubMed/NCBI
25	Meisner M, Tschaikowsky K, Palmaers T and Schmidt J: Comparison of procalcitonin (PCT) and C-reactive protein (CRP) plasma concentrations at different SOFA scores during the course of sepsis and MODS. Crit Care. 3:45–50. 1999. View Article : Google Scholar
26	Haasper C, Kalmbach M, Dikos GD, et al: Prognostic value of procalcitonin (PCT) and/or interleukin-6 (IL-6) plasma levels after multiple trauma for the development of multi organ dysfunction syndrome (MODS) or sepsis. Technol Health Care. 18:89–100. 2010.PubMed/NCBI
27	Ramirez P, Garcia MA, Ferrer M, et al: Sequential measurements of procalcitonin levels in diagnosing ventilator-associated pneumonia. Eur Respir J. 31:356–362. 2008. View Article : Google Scholar
28	Hammer S, Fuchs AT, Rinker C, et al: Interleukin-6 and procalcitonin in serum of children undergoing cardiac surgery with cardiopulmonary bypass. Acta Cardiol. 59:624–629. 2004. View Article : Google Scholar
29	Denizot Y, Lorgeot V, Cornu E and Nathan N: Plasma leukaemia inhibitory factor, interleukin 6 and soluble interleukin 6 receptor levels during cardiopulmonary bypass with extracorporeal circulation. Cytokine. 10:303–306. 1998. View Article : Google Scholar : PubMed/NCBI
30	Póvoa P: C-reactive protein: a valuable marker of sepsis. Intensive Care Med. 28:235–243. 2002. View Article : Google Scholar : PubMed/NCBI